These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24517155)

  • 21. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.
    Behan LA; Rogers B; Hannon MJ; O'Kelly P; Tormey W; Smith D; Thompson CJ; Agha A
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):505-13. PubMed ID: 21521342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
    Johannsson G; Bergthorsdottir R; Nilsson AG; Lennernas H; Hedner T; Skrtic S
    Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid.
    Chikada N; Imaki T; Hotta M; Sato K; Takano K
    Endocr J; 2004 Jun; 51(3):355-60. PubMed ID: 15256782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diurnal rhythm of adrenocorticotropic hormone secretion in the assessment of the adequacy of replacement therapy in primary chronic adrenal failure.
    Fadeev VV; Gitel EP; Mel'nichenko GA
    Neurosci Behav Physiol; 2001; 31(3):237-42. PubMed ID: 11430565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addison's disease.
    Nieman LK; Chanco Turner ML
    Clin Dermatol; 2006; 24(4):276-80. PubMed ID: 16828409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
    Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
    J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution.
    Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
    J Clin Endocrinol Metab; 1998 Mar; 83(3):736-43. PubMed ID: 9506718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Laboratory monitoring of therapy in Addison's disease].
    Kreze A; Kreze-Spirová E; Putz Z
    Vnitr Lek; 1996 Sep; 42(9):627-31. PubMed ID: 8984771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How should the plasma ACTH level in treated Addison's disease patients be interpreted?].
    Pehuet-Figoni M; Bertagna X; Girard F; Bricaire H; Luton JP
    Ann Endocrinol (Paris); 1989; 50(1):54-7. PubMed ID: 2543260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroids and the cardiovascular response to stress: a pilot study of the 35% CO2 challenge in Addison's disease.
    Kaye JM; Lightman SL
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):282-6. PubMed ID: 16918945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease.
    Methlie P; Husebye EE; Hustad S; Lien EA; Løvås K
    Eur J Endocrinol; 2011 Nov; 165(5):761-9. PubMed ID: 21896619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prolonged administration of CRF on plasma concentrations of ACTH in patients with Addison's disease.
    Pirich K; Vierhapper H; Nowotny P; Waldhäusl W
    Exp Clin Endocrinol; 1986 Jul; 87(2):208-10. PubMed ID: 3019743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on cortisol substitution therapy in patients with adrenal insufficiency.
    Nickelsen T; Schulz F; Demisch K
    Exp Clin Endocrinol; 1983 Jul; 82(1):35-41. PubMed ID: 6311594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
    Peacey SR; Wright D; Aye M; Moisey R
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):94-8. PubMed ID: 22151005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.